Michael Linn

861 total citations
14 papers, 729 citations indexed

About

Michael Linn is a scholar working on Oncology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michael Linn has authored 14 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michael Linn's work include Neuroscience and Neuropharmacology Research (4 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and HER2/EGFR in Cancer Research (3 papers). Michael Linn is often cited by papers focused on Neuroscience and Neuropharmacology Research (4 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and HER2/EGFR in Cancer Research (3 papers). Michael Linn collaborates with scholars based in United States, Switzerland and Serbia. Michael Linn's co-authors include Dejan Djurić, Eric Fabian, Karl Kolter, Eva-Maria Collnot, Katja Hempel, Claus‐Michael Lehr, Kenneth Kolinsky, Brian Higgins, Kathryn Packman and David Heimbrook and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Psychopharmacology.

In The Last Decade

Michael Linn

14 papers receiving 716 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Linn United States	11	323	247	159	115	67	14	729
Venkata Mahidhar Yenugonda United States	13	356 1.1×	109 0.4×	83 0.5×	55 0.5×	31 0.5×	26	684
Lukas Klumpp Germany	15	343 1.1×	141 0.6×	161 1.0×	65 0.6×	100 1.5×	25	708
Na Qu China	14	365 1.1×	92 0.4×	34 0.2×	82 0.7×	44 0.7×	56	754
Klaus Urbahns Germany	15	283 0.9×	192 0.8×	21 0.1×	53 0.5×	61 0.9×	27	683
Sarah Giacometti France	14	296 0.9×	259 1.0×	16 0.1×	57 0.5×	57 0.9×	25	690
Gérald Tuffin Switzerland	12	291 0.9×	191 0.8×	21 0.1×	28 0.2×	41 0.6×	15	684
Hongyan Du United States	20	537 1.7×	73 0.3×	32 0.2×	164 1.4×	13 0.2×	39	899
Eleanor Canova‐Davis United States	21	715 2.2×	113 0.5×	38 0.2×	25 0.2×	72 1.1×	34	1.3k
Xiaoming Lu China	19	522 1.6×	129 0.5×	21 0.1×	72 0.6×	31 0.5×	36	917
Eva Prchalová United States	12	504 1.6×	253 1.0×	79 0.5×	77 0.7×	20 0.3×	18	1.2k

Countries citing papers authored by Michael Linn

Since Specialization

Citations

This map shows the geographic impact of Michael Linn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Linn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Linn more than expected).

Fields of papers citing papers by Michael Linn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Linn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Linn. The network helps show where Michael Linn may publish in the future.

Co-authorship network of co-authors of Michael Linn

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Linn. A scholar is included among the top collaborators of Michael Linn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Linn. Michael Linn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Higgins, Brian, Kelli Glenn, Antje‐Christine Walz, et al.. (2014). Preclinical Optimization of MDM2 Antagonist Scheduling for Cancer Treatment by Using a Model-Based Approach. Clinical Cancer Research. 20(14). 3742–3752. 50 indexed citations

Varagić, Zdravko, Jovana Kovačević, Michael Linn, et al.. (2013). Insights into functional pharmacology of α1 GABAA receptors: how much does partial activation at the benzodiazepine site matter?. Psychopharmacology. 230(1). 113–123. 3 indexed citations

Warnock, Kaitlin T., Ojas A. Namjoshi, Michael Linn, et al.. (2013). Triple monoamine uptake inhibitors demonstrate a pharmacologic association between excessive drinking and impulsivity in high‐alcohol‐preferring (HAP) mice. Addiction Biology. 20(2). 236–247. 11 indexed citations

Sawyer, Eileen K., et al.. (2013). Little Evidence of a Role for theα1GABA_ASubunit‐Containing Receptor in a Rhesus Monkey Model of Alcohol Drinking. Alcoholism Clinical and Experimental Research. 38(4). 1108–1117. 10 indexed citations

Kolinsky, Kenneth, Christian Tovar, Yue Zhang, et al.. (2011). Preclinical evaluation of the novel multi-targeted agent R1530. Cancer Chemotherapy and Pharmacology. 68(6). 1585–1594. 10 indexed citations

Linn, Michael, Eva-Maria Collnot, Dejan Djurić, et al.. (2011). Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo. European Journal of Pharmaceutical Sciences. 45(3). 336–343. 212 indexed citations

Savić, Miroslav M., Jelena Kukić‐Marković, Renée J. Grayer, et al.. (2010). Behavioural characterization of four endemic Stachys taxa. Phytotherapy Research. 24(9). 1309–1316. 14 indexed citations

Luistro, Leopoldo, Wei He, Melissa Smith, et al.. (2009). Preclinical Profile of a Potent γ-Secretase Inhibitor Targeting Notch Signaling with In vivo Efficacy and Pharmacodynamic Properties. Cancer Research. 69(19). 7672–7680. 154 indexed citations

Savić, Miroslav M., et al.. (2009). The differential role of α1- and α5-containing GABAA receptors in mediating diazepam effects on spontaneous locomotor activity and water-maze learning and memory in rats. The International Journal of Neuropsychopharmacology. 12(9). 1179–1179. 47 indexed citations

10.

Higgins, Brian, Kenneth Kolinsky, Michael Linn, et al.. (2007). Antitumor activity of capecitabine and bevacizumab combination in a human estrogen receptor-negative breast adenocarcinoma xenograft model.. PubMed. 27(4B). 2279–87. 21 indexed citations

11.

Savić, Miroslav M., Dragan Obradović, Nenad D. Ugrešić, et al.. (2006). Benzodiazepine site inverse agonists and locomotor activity in rats: Bimodal and biphasic influence. Pharmacology Biochemistry and Behavior. 84(1). 35–42. 8 indexed citations

12.

Chen, Jianping, Melissa Smith, Kenneth Kolinsky, et al.. (2006). Antitumor activity of HER1/EGFR tyrosine kinase inhibitor erlotinib, alone and in combination with CPT-11 (irinotecan) in human colorectal cancer xenograft models. Cancer Chemotherapy and Pharmacology. 59(5). 651–659. 21 indexed citations

13.

Muruganandham, Manickam, Mihaela Lupu, Jonathan P. Dyke, et al.. (2006). Preclinical evaluation of tumor microvascular response to a novel antiangiogenic/antitumor agent RO0281501 by dynamic contrast-enhanced MRI at 1.5 T. Molecular Cancer Therapeutics. 5(8). 1950–1957. 42 indexed citations

14.

Higgins, Brian, Kenneth Kolinsky, Melissa Smith, et al.. (2004). Antitumor activity of erlotinib (OSI-774, Tarceva) alone or in combination in human non-small cell lung cancer tumor xenograft models. Anti-Cancer Drugs. 15(5). 503–512. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact